Renal function alters the association of lipoprotein(a) with cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a prospective cohort study
Guyu Zeng, Pei Zhu, Deshan Yuan, Peizhi Wang, Tianyu Li, Qinxue Li, Jingjing Xu, Xiaofang Tang, Ying Song, Yan Chen, Ce Zhang, Sida Jia, Ru Liu, Lin Jiang, Lei Song, Runlin Gao, Yuejin Yang, Xueyan Zhao, Jinqing Yuan- Transplantation
- Nephrology
Abstract
Background and hypothesis
lipoprotein(a) [Lp(a)] and renal dysfunction are both independent risk factors for cardiovascular disease. However, it remains unclear whether renal function mediates the association between Lp(a) and cardiovascular outcomes in patients undergoing percutaneous coronary intervention (PCI).
Methods
From a large prospective cohort study, 10 435 eligible patients undergoing PCI from January 2013 to December 2013 were included in our analysis. Patients were stratified into three renal function groups according to their baseline estimated glomerular filtration rate (eGFR) (<60; 60–90; ≥90 ml/min/1.73m2). The primary endpoint was a composite of all-cause death, nonfatal MI, ischemic stroke, and unplanned revascularization [major adverse cardiac and cerebrovascular events (MACCE)].
Results
Over a median follow-up of 5.1 years, a total of 2 144 MACCE events occurred. After multivariable adjustment, either eGFR <60 ml/min/1.73m2 or elevated Lp(a) conferred a significantly higher MACCE risk. Higher Lp(a) was significantly associated with an increased risk of MACCE in patients with eGFR <60 ml/min/1.73m2. However, this association was weakened in subjects with only mild renal impairment and diminished in those with normal renal function. A significant interaction for MACCE between renal categories and Lp(a) was observed (P = 0.026). Patients with concomitant Lp(a) ≥30 mg/dl and eGFR <60 ml/min/1.73m2 experienced worse cardiovascular outcomes compared with those without.
Conclusion
The significant association between Lp(a) and cardiovascular outcomes was mediated by renal function in patients undergoing PCI. Lp(a)-associated risk was more pronounced in patients with worse renal function, suggesting close monitoring and aggressive management are needed in this population.